Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study

This multicentre, randomized, phase II study was conducted to examine whether the addition of mogamulizumab, a humanized anti‐CC chemokine receptor 4 antibody, to mLSG15, a dose‐intensified chemotherapy, further increases efficacy without compromising safety of patients with newly diagnosed aggressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishida, Takashi, Jo, Tatsuro, Takemoto, Shigeki, Suzushima, Hitoshi, Uozumi, Kimiharu, Yamamoto, Kazuhito, Uike, Naokuni, Saburi, Yoshio, Nosaka, Kisato, Utsunomiya, Atae, Tobinai, Kensei, Fujiwara, Hiroshi, Ishitsuka, Kenji, Yoshida, Shinichiro, Taira, Naoya, Moriuchi, Yukiyoshi, Imada, Kazunori, Miyamoto, Toshihiro, Akinaga, Shiro, Tomonaga, Masao, Ueda, Ryuzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Haematological Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024033/
https://www.ncbi.nlm.nih.gov/pubmed/25733162
http://dx.doi.org/10.1111/bjh.13338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024033/
https://www.ncbi.nlm.nih.gov/pubmed/25733162
http://dx.doi.org/10.1111/bjh.13338

Ejemplares similares